Moderator: Abdullah Kutlar, MD Medical College of Georgia
Speakers: 1. Kenneth Bridges, MD, Global Blood Therapeutics (GBT): “Voxelotor in sickle cell disease”
2. Yogen Saunthararajah MD, Cleveland Clinic Foundation: "Oral decitabine as Hb F inducer in sickle cell disease: early phase trials and future prospects”
3. Robert Hurley, MD, PhD, Wake Forrest University: “Management of acute painful episodes in SCD: beyond opioids”
4. Abdullah Kutlar MD, Medical College of Georgia: “Endothelin receptor blockade in sickle cell disease”
